Insider Transactions last 24 months for Apellis Pharmaceuticals, Inc.  -  NSDQ: APLS

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Francois CedricChief Executive Officer03/11/2026AGIndirectCOM64,869$0.00$0.00372,815
Francois CedricChief Executive Officer03/11/2026DGDirectCOM64,869$0.00$0.00425,968
Dolsten MikaelDirector02/27/2026AADirectCOM14,312$0.00$0.0014,312
Delong Mark JeffreyChief Business & Strat Officer02/11/2026DSDirectCOM368$22.15$8,152.56114,591
Francois CedricChief Executive Officer02/03/2026AMDirectCOM8,840$3.76$33,238.40490,837
Francois CedricChief Executive Officer01/28/2026AADirectCOM195,952$0.00$0.00481,997
Watson David O.General Counsel01/28/2026AADirectCOM55,986$0.00$0.00144,517
Sullivan Timothy EugeneChief Financial Officer01/28/2026AADirectCOM58,140$0.00$0.00152,041
Nicholson NurChief Technical Officer01/28/2026AADirectCOM45,220$0.00$0.00116,338
Meltzer LeslieChief Research and Development01/28/2026AADirectCOM45,220$0.00$0.00107,024
Deschatelets PascalChief Scientific Officer01/28/2026AADirectCOM25,840$0.00$0.001,177,222
Delong Mark JeffreyChief Business & Strat Officer01/28/2026AADirectCOM36,606$0.00$0.00114,959
Chopas James GeorgeVP/Chief Accounting Officer01/28/2026AADirectCOM16,150$0.00$0.0065,955
Boucher KelleyChief People Officer01/28/2026AADirectCOM30,146$0.00$0.00127,804
Watson David O.General Counsel01/22/2026DSDirectCOM7,832$21.77$170,466.6188,531
Sullivan Timothy EugeneChief Financial Officer01/22/2026DSDirectCOM10,287$21.77$223,900.6793,901
Nicholson NurChief Technical Officer01/22/2026DSDirectCOM7,725$21.77$168,137.7271,118
Francois CedricChief Executive Officer01/22/2026DSDirectCOM27,192$21.77$591,844.76286,045
Deschatelets PascalChief Scientific Officer01/22/2026DSDirectCOM5,928$21.77$129,025.291,151,382
Delong Mark JeffreyChief Business & Strat Officer01/22/2026DSDirectCOM3,371$21.77$73,371.1678,353
Chopas James GeorgeVP/Chief Accounting Officer01/22/2026DSDirectCOM2,064$21.77$44,923.7949,805
Baumal CarolineChief Medical Officer01/22/2026DSDirectCOM2,797$21.77$60,877.8286,527
Watson David O.General Counsel01/20/2026DSDirectCOM2,475$19.79$48,987.4396,363
Sullivan Timothy EugeneChief Financial Officer01/20/2026DSDirectCOM2,892$19.79$57,241.07104,188
Nicholson NurChief Technical Officer01/20/2026DSDirectCOM2,203$19.79$43,603.7678,843
1   2  3  4  5  6  7  Next Last  You are at page 1 of 7 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel